
Figure 1
Click to enlarge |
Delivery into any cell type, including primary cells, for unprecedented flexibility and discovery
RNAi research is no longer constrained by cell types that are resistant to lipid-based delivery reagents. Accell siRNA delivers knockdown in every cell type tested to date.
|